99mTc-pertechnetate cut-off to distinguish Graves' disease from subacute thyroiditis

Area of Science:

• Nuclear Medicine
• Endocrinology
• Diagnostic Imaging

Background:

• Thyrotoxicosis diagnosis relies on identifying the underlying cause.
• Thyroid uptake of 99mTc-pertechnetate is a key diagnostic parameter.
• Differentiating Graves' disease from subacute thyroiditis can be challenging.

Purpose of the Study:

• To determine the diagnostic cut-off value of 99mTc-pertechnetate uptake in the thyroid gland.
• To differentiate Graves' disease from subacute thyroiditis using thyroid uptake.
• Establish a reliable index for differential diagnosis of thyrotoxicosis.

Main Methods:

• Study included 60 patients: 30 with Graves' disease and 30 with subacute thyroiditis.
• Assessed biochemical parameters, thyroid scintigraphy, and percentage thyroidal 99mTc-pertechnetate uptake.
• Utilized Receiver Operating Characteristic (ROC) analysis to determine the cut-off value.

Main Results:

• Mean 99mTc-pertechnetate uptake was significantly higher in the Graves' group compared to the subacute thyroiditis group (P <0.001).
• A 1.1% uptake cut-off value demonstrated 97% sensitivity and 95% specificity.
• The results indicate a statistically significant difference in uptake between the two conditions.

Conclusions:

• A 1.1% 99mTc-pertechnetate uptake cut-off is a valuable tool for differentiating Graves' disease from subacute thyroiditis.
• This index is particularly useful when conventional methods struggle to distinguish between these two thyroid conditions.
• The study provides a clear, quantitative measure to aid in the differential diagnosis of thyrotoxicosis.